Most Clicked DiabetesPro SmartBrief Stories

1. Patients on sulfonylurea/insulin combo show higher death risk

DiabetesPro SmartBrief | Dec 18, 2014

Diabetes patients who were on sulfonylurea plus insulin treatment exhibited a two to fivefold increased odds of mortality compared with those who took a metformin/insulin combo, a study indicated. The findings appear in Diabetologia. Healio (free registration) (12/16)

2. Low blood glucose raises heart, mortality risk in diabetes

DiabetesPro SmartBrief | Dec 16, 2014

A study in Diabetes Care revealed insulin-treated diabetes patients who suffered hypoglycemia were at an increased risk of cardiovascular events and all-cause mortality. Healio (free registration) (12/15)

3. White fat cells can be reprogrammed, study finds

DiabetesPro SmartBrief | Dec 16, 2014

The protein KLF11 can be manipulated to reprogram white fat cells into brown fat cells, a process that may help prevent and treat obesity, Danish researchers reported in the journal Genes and Development. Researchers used a type 2 diabetes drug to aid the conversion into cells that provide energy to the body more readily. (12/13)

4. Diabetes patients show higher cancer incidence in study

DiabetesPro SmartBrief | Dec 16, 2014

Patients with type 1 or type 2 diabetes exhibit higher rates of cancer and cancer-related mortality than the general population, according to new research. Of particular concern are cancers of the pancreas, liver, endometrium and kidney, among others. The results appear in Diabetes Care. Medscape (free registration) (12/15)

5. Free online materials for patient education

DiabetesPro SmartBrief | Dec 18, 2014

The American Diabetes Association has developed a free resource for accessing our print-on-demand patient materials. Our new Patient Education Library has a variety of patient materials that can be saved and printed as needed. Topics include diabetes, prediabetes, complications, nutrition and prevention. New pieces are added as they become available, so check back regularly for new content. Search the materials. Blank (11/10)

6. FDA breakthrough status granted to Lucentis for diabetic retinopathy

DiabetesPro SmartBrief | Dec 17, 2014

Genentech's Lucentis, or ranibizumab, secured breakthrough therapy status from the FDA as a treatment for diabetic retinopathy. If FDA approval is granted, diabetic retinopathy would be the fourth approved indication since 2006 for the drug. Healio (free registration) (12/15)

7. Study links flavonoids, healthy aging in women

DiabetesPro SmartBrief | Dec 16, 2014

Middle-aged women have an improved likelihood of healthy aging with a flavonoid-rich diet, according to a study in The American Journal of Clinical Nutrition that followed more than 13,800 women through a 15-year period. The women who noted eating more flavonoid-rich foods, such as citrus fruits, dark chocolate and berries, were more likely to exhibit healthy aging for both physical and mental health. (12/11)

8. Feds tout savings tied to pregestational diabetes care

DiabetesPro SmartBrief | Dec 17, 2014

CDC researchers estimated that providing preconception care for pregestational diabetes in patients ages 15 to 44 could save up to $5.5 billion. The results appear in the American Journal of Obstetrics & Gynecology. Pharmacy Times online (12/15)

9. Data show yoga offers heart benefits similar to aerobics

DiabetesPro SmartBrief | Dec 17, 2014

Researchers in the Netherlands who analyzed data from 37 studies found yoga to be as beneficial as aerobics in reducing heart disease risk. The study in the European Journal of Preventive Cardiology says yoga reduced cardiovascular risk factors compared with no exercise, and it had even greater results when combined with statin medications and used by patients with heart disease. Telegraph (London) (tiered subscription model), The (12/16)

10. Study: Type 2 diabetes risk higher in certain blood groups

DiabetesPro SmartBrief | Dec 19, 2014

French scientists have found that people whose blood is in the type A, B and AB blood groups are more likely to develop type 2 diabetes than those in the O group. The study of more than 82,000 women also found that the highest risk was faced by those with type B positive blood, who are 35% more likely to develop type 2 diabetes than those with type O negative blood. The results appear in Diabetologia. HealthDay News (12/19)

Sign up for DiabetesPro SmartBrief

Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more